A growing group of companies is developing new immunology drugs to challenge Dupixent, the blockbuster Sanofi product with a dominating presence in multiple inflammatory indications. North Immunology is joining the …
Health
-
-
In operating rooms across the country, patient warming and patient positioning are often treated as separate clinical priorities. Different teams manage them, different products address them, and different protocols govern …
-
Valuable signals for healthcare marketers live in dozens of places: social media, patient communities, review sites, call centers, healthcare provider portals, digital programs, and beyond. But these signals rarely come …
-
Hospitals struck a bargain with Medicare Advantage plans years ago to drive volume and receive a modest discount. But that partnership model has been deteriorating over the past few years, …
-
The blood-brain barrier keeps pathogens out but it also keeps drugs from reaching the organ. Novartis is boosting its capabilities for brain drug delivery by acquiring a platform technology that …
-
Many of your teen patients are likely using artificial intelligence (AI) chatbots for mental health support. Teens are turning to AI chatbots for “therapy” and companionship at an alarming rate, …
-
Thatch, a health benefits platform, announced on Tuesday that it raised $108 million in funding, reaching a $1 billion valuation. Thatch helps employers offer Individual Coverage Health Reimbursement Arrangements (ICHRAs) …
-
Hospitals’ financial performance slipped in July as outpatient activity cooled down and operating margins fell compared to the prior month, according to data released this week by Kaufman Hall. The …
-
Multiple myeloma is already served by therapies called T cell engagers, but toxicity remains a problem. GSK sees a way to overcome that limitation with a Chimagen Biosciences drug candidate …
-
Billions of dollars are pouring into new U.S. pharmaceutical manufacturing facilities, part of a broader push to bring critical drug production back onshore. And while the design and build phase …